CN101314587B - 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 - Google Patents
一种伊立替康的中间体及其制备方法和伊立替康的制备方法 Download PDFInfo
- Publication number
- CN101314587B CN101314587B CN200710041525XA CN200710041525A CN101314587B CN 101314587 B CN101314587 B CN 101314587B CN 200710041525X A CN200710041525X A CN 200710041525XA CN 200710041525 A CN200710041525 A CN 200710041525A CN 101314587 B CN101314587 B CN 101314587B
- Authority
- CN
- China
- Prior art keywords
- irinotecan
- formula
- preparation
- piperidinyl piperidine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710041525XA CN101314587B (zh) | 2007-05-31 | 2007-05-31 | 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710041525XA CN101314587B (zh) | 2007-05-31 | 2007-05-31 | 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101314587A CN101314587A (zh) | 2008-12-03 |
CN101314587B true CN101314587B (zh) | 2010-10-27 |
Family
ID=40105741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710041525XA Active CN101314587B (zh) | 2007-05-31 | 2007-05-31 | 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101314587B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102627653B (zh) * | 2012-03-20 | 2014-10-29 | 南京臣功制药股份有限公司 | 盐酸伊立替康的制备方法 |
EP2881396A1 (en) * | 2013-12-03 | 2015-06-10 | Synbias Pharma AG | Method for the synthesis of irinotecan |
-
2007
- 2007-05-31 CN CN200710041525XA patent/CN101314587B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101314587A (zh) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6247195B2 (zh) | ||
CN105566338B (zh) | 一种喜树碱类化合物及其制备方法和用途 | |
CN104817574A (zh) | 新型喜树碱衍生物及其抗肿瘤应用 | |
CN103333172A (zh) | 喜树碱缩氨基硫脲类化合物及其制备方法和用途 | |
CN102746314B (zh) | 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途 | |
CN101314587B (zh) | 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 | |
CN102180914A (zh) | 一种2-脱氧-d-葡萄糖的制备方法 | |
CN102321084B (zh) | 苯并[c]吡啶并[4,3,2-mn]吖啶-8-酮的合成方法 | |
CN101148437B (zh) | 碳碳方式连接的双青藤碱衍生物、制备方法及其应用 | |
CN101851195A (zh) | 一种喹啉类化合物、合成方法及其在喜树碱类生物碱合成中的应用 | |
CN113024557B (zh) | 一种Peganumine A生物碱结构简化物及其应用 | |
CN111362990B (zh) | 一种抗肿瘤药物lnd1026-034及其合成方法 | |
CN113880855A (zh) | 一种9-氟喜树碱衍生物的制备及其在抗肿瘤方面的用途 | |
CN103288842B (zh) | 氟取代e环喜树碱类似物及其作为药物的用途 | |
CN101591342B (zh) | 用于喜树碱类化合物制备的关键中间体合成方法 | |
CN103408559A (zh) | 一种喜树碱及其衍生物的快速合成方法 | |
CN1300147C (zh) | 喜树碱衍生物的制备方法 | |
PL195289B1 (pl) | Analog kamptotecyny, związek pośredni, sposób wytwarzania związku pośredniego i zastosowania | |
CN101880285B (zh) | 一种烯丙基取代喜树碱化合物的合成方法 | |
JP5107723B2 (ja) | 新規16員環4”−o−カルバモイルアザライド誘導体及びその製造方法 | |
ITMI20081984A1 (it) | Irinotecan cloridrato cristallino e metodi per la sua preparazione | |
CN111087410A (zh) | 一种阿莫西林杂质g的制备方法 | |
CN1279042C (zh) | 3-芳基-β-咔啉-1-酮类化合物及其制备方法与应用 | |
CN109796462A (zh) | 一种盐酸伊立替康的制备方法 | |
CN102603759B (zh) | 喜树碱e环类似物及其作为药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JINHE BIOLOGICAL TECHNOLOGY CO., LTD., SHANGHAI Free format text: FORMER OWNER: SHANGHAI HENGHE MEDICAL TECHNOLOGY CO., LTD. Effective date: 20100816 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200231 ROOM 411-415, BUILDING 2, NO.2715, LONGWU ROAD, XUHUI DISTRICT, SHANGHAI CITY TO: 201716 A-4, LIANTANG TOWN INDUSTRIAL PARK, QINGPU DISTRICT, SHANGHAI CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100816 Address after: 201716 Shanghai City Industrial Park, Liantang Town Qingpu District A-4 Applicant after: Jinhe Biological Technology Co., Ltd., Shanghai Address before: 200231, room 2, building 2715, 411-415 Wu Long Road, Shanghai, Xuhui District Applicant before: Shanghai Henghe Medical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation for midbody of Irinotecan and preparation for Irinotecan Effective date of registration: 20110119 Granted publication date: 20101027 Pledgee: Bank of Shanghai, Limited by Share Ltd, Qingpu branch Pledgor: Jinhe Biological Technology Co., Ltd., Shanghai Registration number: 2011990000014 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20111230 Granted publication date: 20101027 Pledgee: Bank of Shanghai, Limited by Share Ltd, Qingpu branch Pledgor: Jinhe Biological Technology Co., Ltd., Shanghai Registration number: 2011990000014 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation for midbody of Irinotecan and preparation for Irinotecan Effective date of registration: 20111230 Granted publication date: 20101027 Pledgee: Bank of Shanghai, Limited by Share Ltd, Qingpu branch Pledgor: Jinhe Biological Technology Co., Ltd., Shanghai Registration number: 2011990000531 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130125 Granted publication date: 20101027 Pledgee: Bank of Shanghai, Limited by Share Ltd, Qingpu branch Pledgor: Jinhe Biological Technology Co., Ltd., Shanghai Registration number: 2011990000531 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation for midbody of Irinotecan and preparation for Irinotecan Effective date of registration: 20130125 Granted publication date: 20101027 Pledgee: Bank of Shanghai, Limited by Share Ltd, Qingpu branch Pledgor: Jinhe Biological Technology Co., Ltd., Shanghai Registration number: 2013990000058 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 201715 Shanghai city Qingpu District Liantang Town Mao Dian Road No. 508 Patentee after: Shanghai King bio Pharmaceutical Co., Ltd. Address before: 201716 Shanghai City Industrial Park, Liantang Town Qingpu District A-4 Patentee before: Jinhe Biological Technology Co., Ltd., Shanghai |